Skip to main content
Aprogen, Inc logo

Aprogen, Inc — Investor Relations & Filings

Ticker · 007460 ISIN · KR7007460009 KO Manufacturing
Filings indexed 734 across all filing types
Latest filing 2024-11-22 Major Shareholding Noti…
Country KR South Korea
Listing KO 007460

Aprogen, Inc. is a biopharmaceutical company focused on the research, development, and manufacturing of biologic medicines. The company's core activities are centered on developing both biosimilars and novel drugs, including new protein therapeutics and bispecific antibodies. Its product development is based on proprietary technologies in antibody engineering and recombinant protein engineering.

Recent filings

Filing Released Lang Actions
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding of Stocks, etc.), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership, including special relationships, collateral agreements, and conversion of convertible bonds. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2024-11-22 Korean
분기보고서 (2024.09)
Interim / Quarterly Report Classification · 100% confidence The document is a '분기보고서' (Quarterly Report) for the company 'Aprogen' (주식회사 에이프로젠) for the period ending September 30, 2024. It contains detailed financial information, company history, capital changes, and management information, which is characteristic of a formal quarterly financial filing submitted to the Financial Supervisory Service (FSS) and Korea Exchange (KRX). It is not an announcement of a report, but the report itself. 9M 2024
2024-11-13 Korean
기타안내사항(안내공시)
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory announcement from Aprogen regarding the expiration of a mandatory holding period for shares issued via third-party allocation. It provides specific details on the release date, the number of shares, and the holder. Since this is a regulatory disclosure regarding share status and capital structure changes that does not fit into specific categories like 'Share Issue' or 'Director's Dealing', it is best classified as a general regulatory filing.
2024-11-08 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea (DART system) used to disclose significant changes in share ownership (5% rule). This document specifically details changes in shareholding and collateral agreements for (주)에이프로젠. Based on the provided filing categories, this fits the 'Major Shareholding Notification' (MRQ) classification.
2024-11-07 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership, including convertible bonds and shareholding percentages by major shareholders and special related parties. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2024-11-01 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서) filed with the Financial Services Commission and the Korea Exchange. It details changes in shareholding (specifically convertible bonds) by a major shareholder, (주)하베스트로즈, in the company (주)에이프로젠. This type of filing is a standard regulatory requirement for significant ownership changes, which falls under the 'Major Shareholding Notification' category.
2024-11-01 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.